Phospholipid abnormalities in postmortem schizophrenic brains detected by 31P nuclear magnetic resonance spectroscopy:: a preliminary study

被引:19
作者
Komoroski, RA
Pearce, JM
Griffin, WST
Mrak, RE
Omori, M
Karson, CN
机构
[1] Univ Arkansas Med Sci, Dept Radiol, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Dept Psychiat, Little Rock, AR 72205 USA
[4] Univ Arkansas Med Sci, Dept Biochem, Little Rock, AR 72205 USA
[5] Univ Arkansas Med Sci, Dept Geriatr, Little Rock, AR 72205 USA
[6] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA
[7] Fukui Med Univ, Dept Neuropsychiat, Matsuoka, Fukui 9101193, Japan
关键词
cell membrane; fatty acids; molecular species; phosphatidylinositol; in vitro;
D O I
10.1016/S0925-4927(01)00081-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
It has been hypothesized that schizophrenia arises from cell membrane abnormalities due to changes in phospholipid (PL) composition and metabolism. We have used high resolution, in vitro P-31 nuclear magnetic resonance (NMR) to characterize the PLs in left frontal cortex (gray matter) of postmortem blain from four schizophrenics and five controls. High resolution 31P NMR spectra were obtained in an organic-solvent system to resolve PL classes (headgroups) and in a sodium-cholate, aqueous dispersion system to resolve phosphatidylcholine (PC) molecular species. Multivariate analysis which included the major PC molecular species and phosphatidylinositol (PI) showed a significant difference between schizophrenics rind controls. Analysis of specific interactions showed that the PI was significantly higher in the schizophrenic group than in the control group. There were no differences between the two groups for other individual PL classes, or for individual PL subclasses determined by the linkage type at the sn-l position on glycerol. There was a trend for total PL content to be higher in schizophrenics than in controls. There was no evidence for elevated lysophosphatidylcholine or lysophosphatidylethanolaminc in schizophrenia. The intensity of the PC peak representing molecular species with one saturated and one unsaturated tone or two double bonds) acyl chain was higher for the schizophrenic group than for the control group. Although these results: are not in complete agreement with previous studies, they support the idea that PL abnormalities occur in the brain in schizophrenia and that fatty acid metabolism may be abnormal. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:171 / 180
页数:10
相关论文
共 36 条
[1]
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[2]
Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo [J].
Blüml, S ;
Tan, J ;
Harris, K ;
Adatia, N ;
Karme, A ;
Sproull, T ;
Ross, B .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1999, 23 (02) :272-275
[3]
INCREASED CONCENTRATIONS OF PHOSPHATIDYLINOSITOL (PI) AND DECREASED ESTERIFICATION OF ARACHIDONIC-ACID INTO PHOSPHOLIPIDS IN PLATELETS FROM PATIENTS WITH SCHIZOAFFECTIVE DISORDERS OR ATYPIC PHASIC PSYCHOSES [J].
DEMISCH, L ;
HEINZ, K ;
GERBALDO, H ;
KIRSTEN, R .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1992, 46 (01) :47-52
[4]
THE PLATELET POLYPHOSPHOINOSITIDE SYSTEM IN SCHIZOPHRENIA - THE EFFECTS OF NEUROLEPTIC TREATMENT [J].
ESSALI, MA ;
DAS, I ;
DEBELLEROCHE, J ;
HIRSCH, SR .
BIOLOGICAL PSYCHIATRY, 1990, 28 (06) :475-487
[5]
Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia [J].
Fenton, WS ;
Hibbeln, J ;
Knable, M .
BIOLOGICAL PSYCHIATRY, 2000, 47 (01) :8-21
[6]
Haloperidol improves membrane phospholipid abnormalities in temporal lobes of schizophrenic patients [J].
Fukuzako, H ;
Fukuzako, T ;
Kodama, S ;
Hashiguchi, T ;
Takigawa, M ;
Fujimoto, T .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (04) :542-549
[7]
INCREASED PLATELET PHOSPHOLIPASE A(2) ACTIVITY IN SCHIZOPHRENIA [J].
GATTAZ, WF ;
SCHMITT, A ;
MARAS, A .
SCHIZOPHRENIA RESEARCH, 1995, 16 (01) :1-6
[8]
GATTAZ WF, 1990, BIOL PSYCHIAT, V28, P495
[9]
Glonek T, 1994, P31 NMR SPECTRAL PRO, P283
[10]
Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect [J].
Heimberg, C ;
Komoroski, RA ;
Lawson, WB ;
Cardwell, D ;
Karson, CN .
PSYCHIATRY RESEARCH-NEUROIMAGING, 1998, 83 (02) :105-115